Bayesian Capital Management, LP - MARAVAI LIFESCIENCES HLDGS I ownership

MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of MARAVAI LIFESCIENCES HLDGS I
ValueSharesWeighting
Q2 2022$483,000
-58.0%
17,000
-47.9%
0.09%
-47.7%
Q1 2022$1,151,000
+423.2%
32,645
+522.4%
0.17%
+145.7%
Q4 2021$220,000
+4.3%
5,245
+22.1%
0.07%
+14.8%
Q3 2021$211,0004,2960.06%
Other shareholders
MARAVAI LIFESCIENCES HLDGS I shareholders Q1 2022
NameSharesValueWeighting ↓
GTCR LLC 21,681,033$1,064,105,00026.99%
Ghisallo Capital Management LLC 1,250,000$61,350,0002.33%
Beck Bode, LLC 160,064$7,856,0002.19%
Select Equity Group, L.P. 12,122,011$594,948,300,0002.00%
Pinz Capital Management, LP 83,603$4,103,0001.86%
Monashee Investment Management LLC 185,000$9,080,0001.68%
Ownership Capital B.V. 2,717,559$133,378,0001.51%
Eversept Partners, LP 327,810$16,088,9151.12%
Parkman Healthcare Partners LLC 90,000$4,417,0001.12%
Connacht Asset Management LP 28,569$1,402,0000.91%
View complete list of MARAVAI LIFESCIENCES HLDGS I shareholders